Preparing for the H&Q

Every January, the movers and shakers of biotech come to the Westin St. Francis in San Francisco to see and be seen, exchange information and move money by funding companies and forming partnerships and other alliances. Thousands of bankers, analysts and company executives mix and mingle at JP Morgan's Annual Healthcare Conference (often still called the H&Q), setting the tone for the year in biotech. Those attending the invitation-only conference go to the company presentations and meet in hall

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Every January, the movers and shakers of biotech come to the Westin St. Francis in San Francisco to see and be seen, exchange information and move money by funding companies and forming partnerships and other alliances. Thousands of bankers, analysts and company executives mix and mingle at JP Morgan's Annual Healthcare Conference (often still called the H&Q), setting the tone for the year in biotech. Those attending the invitation-only conference go to the company presentations and meet in hallways and conferences rooms. But the action, especially for those not connected to JP Morgan, also takes place in the hotel's lobby and suites as well as those of surrounding hotels and restaurants. As an associate at the life sciences investment bank Ferghana Partners, I will be holding court in our company's hotel suite, meeting with company executives to hear about their businesses and technologies as well as to consider deals. I will also be traveling around downtown San Francisco, meeting with potential partners and associates. I will report my impressions throughout the conference, running January 9-12.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Justin Silver

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo